Novasep Expands Its HPAPI Manufacturing Facility in France

Novasep (Pompey, France) says it will expand its highly potent active pharmaceutical ingredients (HPAPI) manufacturing capabilities at the company's Le Mans, France facility. The amount of the investment is €3 million ($3.7 million), and the plant expansion is expected to be fully operational by the beginning of 2013, the company says. There is a sharp increase in demand for "targeted and potent" drugs that improve efficacy and reduce side effects, such as antibody-drug conjugates (ADC), Novasep says. The expansion of Novasep's Le Mans...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers